X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (821) 821
Publication (30) 30
Book Review (29) 29
Newspaper Article (19) 19
Newsletter (18) 18
Magazine Article (14) 14
Book Chapter (5) 5
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
drospirenone (778) 778
humans (442) 442
female (435) 435
index medicus (324) 324
obstetrics & gynecology (303) 303
adult (250) 250
oral contraceptives (208) 208
women (198) 198
ethinyl estradiol (171) 171
adolescent (141) 141
estradiol (136) 136
androstenes - administration & dosage (132) 132
young adult (131) 131
ethinylestradiol (130) 130
ethinyl estradiol - administration & dosage (105) 105
middle aged (103) 103
obstetrics and gynecology (102) 102
efficacy (88) 88
androstenes - adverse effects (85) 85
progestogen (84) 84
risk factors (84) 84
oral-contraceptives (81) 81
hormone replacement therapy (80) 80
contraceptives, oral, combined - administration & dosage (78) 78
estrogen (78) 78
contraceptives, oral, combined - adverse effects (76) 76
risk (76) 76
menopause (74) 74
androstenes - therapeutic use (72) 72
contraception (70) 70
health aspects (70) 70
birth control (69) 69
venous thromboembolism (68) 68
progesterone (67) 67
research (65) 65
androstenes - pharmacology (64) 64
endocrinology & metabolism (64) 64
treatment outcome (63) 63
contraceptives (62) 62
levonorgestrel (55) 55
oral contraceptive (54) 54
ethinyl estradiol - adverse effects (53) 53
premenstrual dysphoric disorder (52) 52
safety (52) 52
analysis (51) 51
contraceptives, oral, combined - therapeutic use (51) 51
drug combinations (51) 51
prospective studies (50) 50
drug therapy, combination (49) 49
postmenopausal women (49) 49
acne (48) 48
polycystic ovary syndrome (48) 48
estradiol - administration & dosage (47) 47
pharmacology & pharmacy (47) 47
public, environmental & occupational health (46) 46
reproductive biology (45) 45
desogestrel (43) 43
mineralocorticoid receptor antagonists - therapeutic use (42) 42
dosage and administration (41) 41
double-blind (41) 41
drug administration schedule (41) 41
cycle control (39) 39
double-blind method (39) 39
estrogens - administration & dosage (39) 39
pregnancy (39) 39
ethinyl estradiol - pharmacology (38) 38
ethinyl estradiol - therapeutic use (38) 38
medicine, general & internal (38) 38
mineralocorticoid receptor antagonists - administration & dosage (38) 38
blood-pressure (37) 37
postmenopause (37) 37
blood pressure (36) 36
phenols (36) 36
polycystic ovary syndrome - drug therapy (36) 36
premenstrual syndrome (36) 36
thrombosis (36) 36
combined oral contraceptives (35) 35
metformin (35) 35
renin-aldosterone system (35) 35
testosterone (35) 35
womens health (35) 35
hypertension (34) 34
internal medicine (34) 34
thromboembolism (34) 34
contraceptives, oral, combined - pharmacology (33) 33
quality of life (32) 32
dose-response relationship, drug (31) 31
medicine & public health (31) 31
symptoms (31) 31
17-beta-estradiol (30) 30
body weight (30) 30
care and treatment (30) 30
complications and side effects (30) 30
contraceptives, oral, hormonal - adverse effects (30) 30
drug therapy (30) 30
hormonal contraception (30) 30
hormone therapy (30) 30
menstrual-cycle (30) 30
mineralocorticoid receptor antagonists - adverse effects (30) 30
progestin (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (799) 799
Russian (33) 33
Spanish (10) 10
Korean (8) 8
Polish (6) 6
German (5) 5
French (4) 4
Czech (3) 3
Italian (3) 3
Turkish (3) 3
Portuguese (2) 2
Chinese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Obstetrics & Gynecology, ISSN 0029-7844, 05/2019, Volume 133 Suppl 1, pp. 7 - 7
INTRODUCTION:Estetrol (E4) is a natural human estrogen with selective action in different tissues. A combined oral contraceptive (COC) with E4 15 mg and... 
Composition | Drospirenone | Oral contraceptives | Health aspects | Estrogen | Testing
Journal Article
Obstetrics & Gynecology, ISSN 0029-7844, 05/2019, Volume 133 Suppl 1, pp. 108S - 109S
INTRODUCTION:Progestogen only oral contraceptives are associated with a decreased risk of venous thromboembolism making them indicated in women who are breast... 
Dosage and administration | Contraceptive drugs | Research | Breast feeding | Drospirenone
Journal Article
Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, 12/2019, Volume 98, Issue 12, pp. 1549 - 1557
Introduction Approximately 100 million women currently use combined oral contraceptives. Combined oral contraceptives use is associated with increased risk of... 
drospirenone | estrogen‐free contraception | Pearl index | drospirenone‐only pill | venous thromboembolic events
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 07/2014, Volume 142, pp. 48 - 51
After a worldwide breakdown of hormone therapy [HT] following the publications of the Women's Health Initiative trial and Million Women's Study in 2002–2003,... 
Nomegestrol acetate | Drospirenone | Progestogen | Dienogest
Journal Article
European Journal of Obstetrics and Gynecology, ISSN 0301-2115, 05/2018, Volume 224, pp. 102 - 107
Meniere's disease is caused by an augmented endolymph pressure in the inner ear; symptoms are vertigo, fluctuating hearing loss and tinnitus. Exacerbations has... 
Combined oral contraception | Premenstrual syndrome | Menstrual cycle | Drospirenone | Meniere’s disease
Journal Article
Obstetrics & Gynecology, ISSN 0029-7844, 07/2019, Volume 134, Issue 1, pp. 91 - 101
OBJECTIVE:To elucidate the effects of the intravaginal ring, oral contraceptive pill (OCP), and spermicide plus condom on womenʼs sexual experiences through an... 
SATISFACTION | LUBRICANT USE | DROSPIRENONE | PLEASURE | ORAL-CONTRACEPTIVES | LIFE | OBSTETRICS & GYNECOLOGY
Journal Article
Brazilian Journal of Medical and Biological Research, ISSN 0100-879X, 11/2015, Volume 49, Issue 1
Journal Article
Journal of Gynecologic Oncology (JGO), ISSN 2005-0380, 2018, Volume 29, Issue 5, p. 1
Objective: To determine whether drospirenone/estradiol (DRSP/E2) has an adverse effect on clinical outcomes in surgically staged International Federation of... 
Endometrial Neoplasms | Drospirenone | Estradiol | Hormone Replacement Therapy
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 06/2019, Volume 190, p. 54
Oral contraception is the most commonly used interventional method in the world. However, several women employ the continuous use of these hormones to avoid... 
Evaluation | Pancreatic beta cells | Liver | Ethinyl estradiol | Insulin resistance | Glucose | Oral contraceptives | Drospirenone | Estradiol | Insulin | Dextrose
Journal Article
MATURITAS, ISSN 0378-5122, 09/2008, Volume 61, Issue 1-2, pp. 151 - 157
The synthetic progestins used so far for contraception and menopausal hormone therapy are derived either from testosterone (19-nortestosterone derivatives) or... 
LIPID-METABOLISM | RENIN-ALDOSTERONE SYSTEM | NOMEGESTROL ACETATE | Menopause | BIOAVAILABILITY | GERIATRICS & GERONTOLOGY | OBSTETRICS & GYNECOLOGY | VENOUS THROMBOEMBOLISM | Progestins | REPLACEMENT THERAPY | DROSPIRENONE | Progesterone | MONKEYS | ORAL-CONTRACEPTIVES
Journal Article
Медицинский совет, ISSN 2079-701X, 04/2018, Issue 6, pp. 156 - 160
Healthy aging (anti-aging) involves the prevention of illness and disability, keeping mental and physical activity in tip-top shape, maintaining the meaning... 
menopausal hormonal therapy | skin | drospirenone | estradiol
Journal Article
Contraception, ISSN 0010-7824, 2005, Volume 71, Issue 6, pp. 409 - 416
To compare the effect of ethinyl estradiol 20 μg/drospirenone 3 mg (EE 20 μg/DRSP 3 mg) administered according to a 24/4 regimen with ethinyl estradiol 20... 
Carbohydrate metabolism | Lipid metabolism | Oral contraceptives | Drospirenone
Journal Article
Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 04/2019, Volume 73, Issue 4, pp. 196 - 196
Journal Article
Science of the Total Environment, ISSN 0048-9697, 11/2019, Volume 692, pp. 653 - 659
Drospirenone (DRO) is one of the most commonly used progestins reaching the aquatic environment through wastewater treatment plant effluents. It is a... 
PLHC-1 cells | Lipidomics | Drospirenone | Mass spectrometry | MIXTURES | ENVIRONMENTAL SCIENCES | ACTIVATE | PROGESTERONE | PROGESTOGENS | GESTAGENS | EXPRESSION | SYNTHETIC PROGESTINS | Sewage | Purification | Reproductive organs | Triglycerides | Progesterone | Wastewater | Fatty acids
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.